eltrombopag

Italy

Drugs containing this active substance

  • ELTROMBOPAG OLPHA

    It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (primary) in patients over 1 year of age who have not responded to other medications, and for the treatment of low platelet counts in patients with hepatitis C virus.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag -

    ATC: B02BX05

    Manufacturer: OLPHA AS

  • ELTROMBOPAG VIATRIS

    It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other medications, and for the treatment of low platelet counts in patients with hepatitis C (HCV).

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag -

    ATC: B02BX05

    Manufacturer: VIATRIS LIMITED

  • REVOLVE

    It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other medications, for low platelet counts in patients with hepatitis C, and for adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag -

    ATC: B02BX05

    Manufacturer: NOVARTIS EUROPHARM LIMITED